Aurobindo Pharma Limited has acquired a 26 percent equity stake in Swarnaakshu Solar Power Private Limited and entered into a power purchase agreement for solar power. The initial investment of Rs 0.52 crore was made on June 25, 2026, securing the equity stake.
The total investment in Swarnaakshu is up to Rs 10.40 crore for acquiring 26 percent of the paid-up equity share capital and other securities. Aurobindo Pharma made the initial investment on the same date and executed the power purchase agreement. The remaining investment will be made in stages based on the solar project's progress and fund requirements of Swarnaakshu.
The power purchase agreement was signed under the captive power policy of the Government of Telangana. The solar power generated will be used for captive consumption by Aurobindo Pharma. Swarnaakshu Solar Power Private Limited will supply the power under the terms of the agreement.
Aurobindo Pharma had previously informed the exchanges about the planned investment and power purchase agreement through multiple disclosures. Prior intimation letters were sent on February 6, 2025, March 28, 2025, June 30, 2025, September 26, 2025, December 30, 2025, and March 30, 2026. The completion was disclosed to the National Stock Exchange of India Limited and BSE Limited on June 25, 2026.
Disclaimer: This article is based on company filings submitted to the Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE) and is for informational purposes only. It does not constitute investment advice or a recommendation. Investors should conduct their own research and consult a qualified financial advisor before making investment decisions.